Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-02-07
Original market date: See footnote 1
2020-02-07
Product name:
VASCEPA
DIN:
02495244
Product Monograph/Veterinary Labelling:
Date:
2022-04-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HLS THERAPEUTICS INC
10 Carlson Court, Suite 701
Etobicoke
Ontario
Canada
M9W 6L2
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:06.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
C10AX OTHER LIPID MODIFYING AGENTS
Active ingredient group (AIG) number:See footnote5
0162013001
| Active ingredient(s) | Strength |
|---|---|
| ICOSAPENT ETHYL | 1 G |